Developing as a significant advance in the battle against obesity, this medication is capturing considerable interest . This treatment combines the action of two recognized GLP-1 receptor agonists, dulaglutide , with an additional glucose-dependent hormonal component. Early patient findings have demonstrated significant weight reduction in people